Adiponectin is the most abundant peptide secreted by adipocytes, whose reduction plays a
central role in obesity-related diseases, including insulin resistance/type 2 diabetes and …

Obesity develops when energy intake exceeds energy expenditure. Although most current
obesity therapies are focused on reducing calorific intake, recent data suggest that …

BACKGROUND: There are limited data regarding the relationship between cannabinoids
and metabolic processes. Epidemiologic studies have found lower prevalence rates of …

Dietary ratios of n-3/n-6 polyunsaturated fatty acids (PUFAs) have been implicated in
controlling markers of metabolic disorders, including obesity, insulin resistance (IR) …

Obesity is associated with an increased risk of esophageal disorders, including esophageal
adenocarcinoma, Barrett esophagus and GERD. For reasons yet unknown, the association …

Dysfunction in adipocytes is associated with insulin resistance and type 2 diabetes.
Diabetes-associated anemia has been reported due to the increased non-enzymatic …

Background: Adipose tissue reaches cellular stasis after puberty, leaving adipocytes unable
to significantly expand or renew under normal physiologic conditions. This is problematic in …

There are many indications that confirm the vital role of adipocytokines and PPARγ in
diabetics. Hence, the current investigation aimed to study the modulatory effects of gallic …

Obesity is associated with a high prevalence of erectile dysfunction; however, the
pathophysiological link between obesity and erectile dysfunction remains poorly …

Context: Adiponectin, synthesized by adipocytes, has been shown to be a predictor of type 2
diabetes. Adiponectin circulates in plasma as three oligomeric isoforms. High-molecular …